BSD Medical second one fourth total revenues lower to $271.

BSD Medical second one fourth total revenues lower to $271,883 BSD Medical Company ( a respected supplier of medical systems that deal with cancer and benign illnesses using heat therapy, today reported financial outcomes because of its second fiscal one fourth ended February 29, 2012, including: Money and money equivalents of $14.4 million No debt amount stockholders’ equity of $17 check information .9 million Total revenues of $930,february 29 881 for the half a year ended, 2012, in comparison to total revenues of $951,424 for the half a year ended February 28, 2011 Total revenues of $271,883 for the 90 days ended February 29, 2012, in comparison to total revenues of $444,439 for the 90 days ended February 28, 2011 Net lack of $2,102,598 for the 90 days ended February 29, 2012, and $3,790,003 for the half a year ended February 29, 2012 Net cash found in operating actions of $2,631,february 29 282 for the half a year ended, 2012 Related StoriesNew findings reveal association between colorectal cancer and melanoma medicine treatmentMD Anderson research reveals why chemotherapy medicines not effective for most pancreatic cancer patientsOvarian cancer individuals with a brief history of oral contraceptive use possess better outcomes’We’ve a solid balance sheet, no debt, and believe we are sufficiently capitalized to keep our sales and advertising and product advancement efforts,’ stated Harold Wolcott, President of the ongoing company.

cialis online

The MTX-180 is allowed by These designs to supply larger and even more uniform zones of ablation throughout a single procedure. The U.S. Meals and Medication Administration offers granted the business a 510 clearance to advertise its MicroThermX Microwave Ablation Program for ablation of gentle tissue.. BSD publishes article in technology to improve heat treatment delivery for cancer treatment BSD Medical Company today reported publication of articles on BSD’s pioneering advancement of sophisticated technology to boost the delivery of heat treatment for the treating certain cancerous tumors. This article, ‘Interstitial microwave changeover from hyperthermia to ablation: Traditional perspectives and current tendencies in thermal therapy,’ that was authored by TP Ryan, PF Turner, and B Hamilton, was released in the ‘International Journal of Hyperthermia,’ the premier world-wide journal for initial heat therapy study.